Research Studies

RAD is currently seeking patients to participate in an IVF clinical trial. This is a great opportunity for some of our patients who are contemplating IVF to attain their family building dreams. In addition to helping us advance the field of fertility, participants who qualify will enjoy benefits like free or significantly reduced costs for study medications and treatment.

You may be eligible to participate if you are:

• You are between 18-42 years of age
• Your body mass index (BMI) is between 17.5 and 38.0
• You currently have regular menstrual cycles
• You are preparing to undergo an IVF cycle with a fresh embryo transfer

To learn more about this study, visit clinicaltrials.gov here and here

RAD is currently seeking patients to participate in an IVF clinical trial. In addition to helping us advance the field of fertility, participants who qualify will enjoy benefits like free or significantly reduced costs for study medications and treatment. We have additional research opportunities on the horizon that will start in Fall 2018.

Learn more about this study, visit clinicaltrials.gov

Reproductive Associates of Delaware is currently seeking patients to participate in a fertility research study designed to compare two medications used for controlled ovarian stimulation (COS), in in vitro fertilization (IVF) cycles.

The study medications and some study-related tests and procedures may be provided at no cost to qualified participants.

You may be eligible for the study if you:

• Are between 21-35 years old
• Have a regular menstrual cycle of 21 to 45 days
• Have a history of infertility and desire pregnancy
• Have an AMH (Anti-Mullerian Hormone) ≥ 5 (ng/mL)

Your decision to participate in the study is voluntary and deciding not to participate will not change your care at Reproductive Associates of Delaware.

To learn more about this study along with exclusion criteria, visit clinicaltrials.gov

If you are interested in learning more about the IVF Clinical Trial you can contact Mark Modelski at (302) 602-8779 or email him at mmodelski@radfertility.com

Reproductive Associates of Delaware is participating in the LutrePulse Clinical Research Study. The study is evaluating the ovulation rate in women after receiving an investigational pulsatile gonadotropin-releasing hormone (GnRH) medication. The study requires patients that meet the following criteria.

• You are a woman 18-40 years old
• You have a clinical history or were recently diagnosed with primary amenorrhea with hypogonadotropic hypogonadism
• You desire to become pregnant

If you are interested in learning more about the LutrePulse Hypogonadotropic Hypogonadism Clinical Research Study, please contact Mark Modelski at (302) 602-8779 or email at mmodelski@radfertility.com.

RAD is currently seeking patients to participate in a research study by donating a blood sample that will help evaluate a test that measures Anti-Müllerian hormone (AMH). AMH is a naturally occurring hormone found in both men and women. In women, AMH, is related to the reproductive cycle and the ability to get pregnant, and may help identify women who may have problems getting pregnant because of poor ovarian response.

Eligible participants will be compensated as a result of their volunteer participation in this study.

If you are currently planning to undergo your 1st, 2nd, or 3rd cycle of ovarian stimulation for IVF, you may be eligible to participate in this research study if you meet the following eligibility:

• You are between the ages of 21 and 45 years old.
• You have regular menstual cycles (between 21 and 35 days).
• You have both of your ovaries.
• You are not currently on oral contraceptives.
• You do not have confirmed PCOS.
• You have not had any ovarian surgery within the last year.
• You have not recently had drug or radiation treatment for cancer.
• You are not currently pregnant
• You are willing to provide a blood sample according to the research study.

If you are interested in learning more about the AMH Study and whether you may be eligible to participate, please contact Mark Modelski at (302) 602-8779 or email at mmodelski@radfertility.com.